EP1549761A4 - Methods and compositions for the modification of nucleic acids - Google Patents

Methods and compositions for the modification of nucleic acids

Info

Publication number
EP1549761A4
EP1549761A4 EP03726696A EP03726696A EP1549761A4 EP 1549761 A4 EP1549761 A4 EP 1549761A4 EP 03726696 A EP03726696 A EP 03726696A EP 03726696 A EP03726696 A EP 03726696A EP 1549761 A4 EP1549761 A4 EP 1549761A4
Authority
EP
European Patent Office
Prior art keywords
compositions
modification
methods
nucleic acids
nucleic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP03726696A
Other languages
German (de)
French (fr)
Other versions
EP1549761A1 (en
Inventor
Kevin Plunkett
Andrei Purmal
Boris Zavizion
John Chapman
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
VI Technologies Inc
Original Assignee
VI Technologies Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by VI Technologies Inc filed Critical VI Technologies Inc
Publication of EP1549761A1 publication Critical patent/EP1549761A1/en
Publication of EP1549761A4 publication Critical patent/EP1549761A4/en
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D203/00—Heterocyclic compounds containing three-membered rings with one nitrogen atom as the only ring hetero atom
    • C07D203/04—Heterocyclic compounds containing three-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings
    • C07D203/06—Heterocyclic compounds containing three-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D203/08—Heterocyclic compounds containing three-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring nitrogen atom
    • C07D203/12—Radicals substituted by nitrogen atoms not forming part of a nitro radical
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
    • C12N2750/00011—Details
    • C12N2750/14011—Parvoviridae
    • C12N2750/14311—Parvovirus, e.g. minute virus of mice
    • C12N2750/14361—Methods of inactivation or attenuation
    • C12N2750/14363—Methods of inactivation or attenuation by chemical treatment

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Wood Science & Technology (AREA)
  • Virology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Communicable Diseases (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
EP03726696A 2002-05-06 2003-05-06 Methods and compositions for the modification of nucleic acids Withdrawn EP1549761A4 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US37818402P 2002-05-06 2002-05-06
US378184P 2002-05-06
PCT/US2003/014363 WO2003093512A1 (en) 2002-05-06 2003-05-06 Methods and compositions for the modification of nucleic acids

Publications (2)

Publication Number Publication Date
EP1549761A1 EP1549761A1 (en) 2005-07-06
EP1549761A4 true EP1549761A4 (en) 2006-02-15

Family

ID=29401590

Family Applications (1)

Application Number Title Priority Date Filing Date
EP03726696A Withdrawn EP1549761A4 (en) 2002-05-06 2003-05-06 Methods and compositions for the modification of nucleic acids

Country Status (5)

Country Link
EP (1) EP1549761A4 (en)
JP (1) JP2005524707A (en)
AU (1) AU2003228919A1 (en)
CA (1) CA2484940A1 (en)
WO (1) WO2003093512A1 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040053208A1 (en) * 1995-08-29 2004-03-18 V. I. TECHNOLOGIES, Inc. Methods to selectively inactivate parasites in biological compositions
CA3107314A1 (en) * 2018-07-27 2020-01-30 Zata Pharmaceuticals, Inc. Method for pathogens, microorganisms, and parasites inactivation
CN112342144B (en) * 2020-09-28 2023-02-14 江西农业大学 Aspergillus flavus strain and application thereof

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000044720A1 (en) * 1999-01-29 2000-08-03 V.I. Technologies, Inc. Synthesis of ethyleneimine dimer

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6352695B1 (en) * 1997-10-03 2002-03-05 V.I. Technologies, Inc. Methods and compositions for the selective modification of nucleic acids
US6093564A (en) * 1997-10-03 2000-07-25 V.I. Technologies, Inc. Methods and compositions for the selective modification of nucleic acids

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000044720A1 (en) * 1999-01-29 2000-08-03 V.I. Technologies, Inc. Synthesis of ethyleneimine dimer

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
PIPER J R ET AL: "S-2-(OMEGA-AMINOALKYLAMINO)ETHYL DIHYDROGEN PHOSPHOROTIOATES AND RELATED COMPOUNDS AS POTENTIAL ANTIRADIATION AGENTS", JOURNAL OF MEDICINAL CHEMISTRY, AMERICAN CHEMICAL SOCIETY. WASHINGTON, US, vol. 12, 1969, pages 236 - 243, XP001061529, ISSN: 0022-2623 *
See also references of WO03093512A1 *
YUAN ET AL: "Cytotoxic activity of N1- and N-8-aziridinyl analogs of spermidine", BIOCHEMICAL PHARMACOLOGY, vol. 47, no. 9, 1994, GREAT BRITAIN, pages 1587 - 1592, XP002358851 *

Also Published As

Publication number Publication date
JP2005524707A (en) 2005-08-18
EP1549761A1 (en) 2005-07-06
WO2003093512A1 (en) 2003-11-13
CA2484940A1 (en) 2003-11-13
AU2003228919A1 (en) 2003-11-17

Similar Documents

Publication Publication Date Title
AU2003286535A8 (en) Methods of manipulating nucleic acids
AU2003270310A8 (en) Compositions and methods for synthesizing nucleic acids
PL375691A1 (en) Imidazolopyridines and methods of making and using the same
AU2003285012A8 (en) Compositions comprising zopiclone derivatives and methods of making and using the same
AU2003239129A8 (en) Methods and compositions for dna manipulation
AU2003256805A8 (en) Compounds compositions and methods
EP1487776A4 (en) Acid and ester compounds and methods of using the same
AU2003257109A8 (en) Compositions and methods for molecular biology
EP1638513A4 (en) High unsaponifiables and methods of using the same
EP1572991A4 (en) Compositions and methods for hydroxilating epothilones
AU2002353310A8 (en) Method for the preparation of nucleic acids
AU2002311759A8 (en) Methods and compositions for analyzing nucleic acids
AU2003276844A8 (en) Formulations of modified antibodies and methods of making the same
GB0218215D0 (en) Amplification of nucleic acids
AU2003219719A8 (en) Methods and compositions for detecting differences between nucleic acids
EP1163340A4 (en) Compositions and methods for the modification of gene expression
EP1549761A4 (en) Methods and compositions for the modification of nucleic acids
AU2003268340A8 (en) Methods and compositions for the inhibition of dna repair protein xrcc-3
AU2003224928A8 (en) Compositions and methods for cloning nucleic acids
AU2003297297A8 (en) Elf3 gene compositions and methods
AU2003270143A8 (en) Improved methods for the synthesis of nucleic acids
EP1660038A4 (en) Steroidal compositions containing hydroxycarboxylic acids and methods of using the same
GB0314158D0 (en) Coating composition and methods of using the same
AU2002303827A1 (en) Compositions and methods for extension of nucleic acids
AU2003222173A1 (en) Nucleic acid compositions and methods for use

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20041203

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LI LU MC NL PT RO SE SI SK TR

AX Request for extension of the european patent

Extension state: AL LT LV MK

DAX Request for extension of the european patent (deleted)
RBV Designated contracting states (corrected)

Designated state(s): DE FR GB

RIC1 Information provided on ipc code assigned before grant

Ipc: C07D 203/12 20060101ALI20051220BHEP

Ipc: C07H 21/00 20060101ALI20051220BHEP

Ipc: C12Q 1/68 20060101AFI20031119BHEP

A4 Supplementary search report drawn up and despatched

Effective date: 20051230

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20051201

RIN1 Information on inventor provided before grant (corrected)

Inventor name: CHAPMAN, JOHN

Inventor name: ZAVIZION, BORIS

Inventor name: PURMAL, ANDREI, A.

Inventor name: PLUNKETT, KEVIN